Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder
- 1 March 2019
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 90, 142-160
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Influence of GluN2 subunit identity on NMDA receptor functionNeuropharmacology, 2013
- Perineuronal nets protect fast-spiking interneurons against oxidative stressProceedings of the National Academy of Sciences, 2013
- Differential Role of NR2A and NR2B Subunits in N-Methyl-D-Aspartate Receptor Antagonist-Induced Aberrant Cortical Gamma OscillationsBiological Psychiatry, 2012
- Sporadic autism exomes reveal a highly interconnected protein network of de novo mutationsNature, 2012
- Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related DeficitsCell, 2011
- D-Cycloserine Facilitates Socially Reinforced Learning in an Animal Model Relevant to Autism Spectrum DisordersBiological Psychiatry, 2011
- A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behaviorMolecular Psychiatry, 2011
- mTOR signaling: At the crossroads of plasticity, memory and diseaseTrends in Neurosciences, 2010
- Genetic loss of D‐amino acid oxidase activity reverses schizophrenia‐like phenotypes in miceGenes, Brain and Behavior, 2010
- Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophreniaGenes, Brain and Behavior, 2009